Literature DB >> 16417782

Clinical study on effect of Osteoking in preventing postoperational deep venous thrombosis in patients with intertrochanteric fracture.

Hong-bin Zhao1, Min Hu, Hong-yu Zheng, Hong-suo Liang, Xiao-song Zhu.   

Abstract

OBJECTIVE: To evaluate the effect of Osteoking ( masculine(1)i) in preventing postoperational deep venous thrombosis (DVT) in patients with intertrochanteric fracture (ITF).
METHODS: With prospective and randomized controlled clinical design adopted, 62 patients with ITF after operation were assigned into 2 groups, the tested group and the control group, Osteoking (25 ml every other day) and Sanchi-dansheng tablets (3 tablets thrice a day) were given orally to them respectively for 10 days. Difference of round length of thighs and shanks between two sides were measured on the 10th day and Doppler ultrasonic examination on the fractured leg was carried out.
RESULTS: The occurrence rate of DVT in the tested group was 9.4%, which was lower than that in the control group (30.0%, P < 0.05). All the difference of round lengths, either that of the thigh or the shank, was less in the tested group than that in the control group, showing statistical significance (P < 0.05).
CONCLUSION: Osteoking has a satisfactory effect in preventing postoperational DVT in patients with ITF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16417782     DOI: 10.1007/bf02835793

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  7 in total

1.  [Low-molecular-weight heparin for preventing deep-vein thrombosis after total joint arthroplasty].

Authors:  G Yang; H Lu; J Gao; B Kou; Y Yuan; B Xu
Journal:  Zhonghua Wai Ke Za Zhi       Date:  2000-01

Review 2.  Clinical practice. Treatment of deep-vein thrombosis.

Authors:  Shannon M Bates; Jeffrey S Ginsberg
Journal:  N Engl J Med       Date:  2004-07-15       Impact factor: 91.245

3.  The treatment of trochanteric fractures of the femur.

Authors:  E M EVANS
Journal:  J Bone Joint Surg Br       Date:  1949-05

Review 4.  Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety.

Authors:  J Hirsh; T E Warkentin; S G Shaughnessy; S S Anand; J L Halperin; R Raschke; C Granger; E M Ohman; J E Dalen
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

Review 5.  Prevention of venous thromboembolism after acute ischemic stroke.

Authors:  P W Kamphuisen; G Agnelli; M Sebastianelli
Journal:  J Thromb Haemost       Date:  2005-06       Impact factor: 5.824

Review 6.  Venous thrombosis: a multicausal disease.

Authors:  F R Rosendaal
Journal:  Lancet       Date:  1999-04-03       Impact factor: 79.321

Review 7.  Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis.

Authors:  G P Clagett; J S Reisch
Journal:  Ann Surg       Date:  1988-08       Impact factor: 12.969

  7 in total
  2 in total

1.  Effects of OsteoKing on osteoporotic rabbits.

Authors:  Lifen Dai; Haiying Wu; Shan Yu; Hongbin Zhao; Lanjie Xue; Ming Xu; Zhiqiang Shen; Min Hu
Journal:  Mol Med Rep       Date:  2015-03-26       Impact factor: 2.952

2.  Effect of Osteoking on the osteogenic and adipogenic differentiation potential of rat bone marrow mesenchymal stem cells in vitro.

Authors:  Congtao Yu; Lifen Dai; Zhaoxia Ma; Hongbin Zhao; Yong Yuan; Yunfeng Zhang; Pengfei Bao; Yanfang Su; Daiping Ma; Change Liu; Xingfei Wu; Jinxue Liu; Yanjiao Li; Bing Wang; Min Hu
Journal:  BMC Complement Altern Med       Date:  2019-01-31       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.